Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 4Not yet recruiting 1

Sponsor Class

OTHER 12INDUSTRY 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 4Plasma cell 1Genitourinary 1

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

ganitumab 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Jaundice × Clear all
NCT01231347 2024-07-16

GAMMA

NantCell, Inc.

Phase 3 Completed
800 enrolled 11 charts
Gastrointestinal

Endocrine Gland Neoplasms, Jaundice, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06276738 2024-05-14

The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

Adenocyte, LLC

Not yet recruiting
1,000 enrolled
Gastrointestinal

Abdominal Neoplasms, Jaundice, Pancreatic Neoplasms

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Celgene

Completed
1,149 enrolled
GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis

NCT02098239 2014-03-27

Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.

Cancer Advances Inc.

Phase 2 Completed
41 enrolled
Gastrointestinal

Jaundice, Pancreatic Neoplasms

NCT00196105 2011-10-03

Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

Cook Group Incorporated

Phase NA Completed
241 enrolled 15 charts
Gastrointestinal

Biliary Tract Neoplasms, Jaundice, Pancreatic Neoplasms, Jaundice, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡